Novel and Recurrent Mutations in the FGFR3 Gene and Double Heterozygosity Cases in a Cohort of Brazilian Patients with Skeletal Dysplasia

Author(s):Show less -

Gomes, Maria E. S. ^[1] ; Kanazawa, Thatiane Y. ^[2] ; Riba, Fernanda R. ^[1] ; Pereira, Natalya G. ^[3] ; Zuma, Maria C. C. ^[1] ; Rabelo, Natana C. ^[1] ; Sanseverino, Maria T. ^[4] ; Horovitz, Dafne D. G. ^[3] ; Llerena, Jr., Juan C. ^{[3, 5, 6]} ; Cavalcanti, Denise P. ^[2] ; Gonzalez, Sayonara ^[1]

Affiliation

^[1] IFF Fiocruz, Lab Med Genom, Dept Genet Med, Rio De Janeiro - Brazil

^[2] Univ Estadual Campinas, FCM, Grp Displasias Esquelet, Dept Genet Med, Sao Paulo - Brazil

^[3] IFF Fiocruz, Ctr Genet Med, Rio De Janeiro - Brazil

^[4] Univ Fed Rio Grande do Sul, Porto Alegre, RS - Brazil

^[5] Fac Arthur Sa Earp Neto, Fac Med Petropolis, Rio De Janeiro - Brazil

^[6] Inst Nacl Genet Med Populac INAGEMP, Porto Alegre, RS - Brazil

• Document type: Journal article
• Source: MOLECULAR SYNDROMOLOGY; v. 9, n. 2, p. 92-99, 2018.
• Web of Science Citations: 5

Abstract

Mutations in the fibroblast growth factor receptor 3 gene (FGFR3) cause achondroplasia (ACH), hypochondroplasia (HCH), and thanatophoric dysplasia types I and II (TDI/TDII). In this study, we performed a genetic study of 123 Brazilian patients with these phenotypes. Mutation hotspots of the FGFR3 gene were PCR amplified and sequenced. All cases had recurrent mutations related to ACH, HCH, TDI or TDII, except for 2 patients. One of them had a classical TDI phenotype but a typical ACH mutation (c.1138G>A) in combination with a novel c.1130T>C mutation predicted as being pathogenic. The presence of the second c.1130T>C mutation likely explained the more severe phenotype. Another atypical patient presented with a compound phenotype that resulted from a combination of ACH and X-linked spondyloepiphyseal dysplasia tarda (OMIM 313400). Next-generation sequencing of this patient's DNA showed double heterozygosity for a typical de novo ACH c.1138G>A mutation and a maternally inherited TRAPPC2c.6del mutation. All mutations were confirmed by Sanger sequencing. A pilot study using high-resolution melting (HRM) technique was also performed to confirm several mutations identified through sequencing. We concluded that for recurrent FGFR3 mutations, HRM can be used as a faster, reliable, and less expensive genotyping test than Sanger sequencing. (c) 2018 S. Karger AG, Basel. (AU)

• FAPESP's process: 15/22145-6 - Contribution to the clinical and etiological study of the skeletal dysplasias and dysostosis in Brazil
• Grantee: Denise Pontes Cavalcanti
• Support Opportunities: Regular Research Grants